+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Optical Preclinical Imaging Market by Product Type, End-Use - Global Forecast 2025-2030- Product Image
Optical Preclinical Imaging Market by Product Type, End-Use - Global Forecast 2025-2030- Product Image
Sale

Optical Preclinical Imaging Market by Product Type, End-Use - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5460284
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Optical Preclinical Imaging Market grew from USD 1.32 billion in 2023 to USD 1.51 billion in 2024. It is expected to continue growing at a CAGR of 14.39%, reaching USD 3.39 billion by 2030.

Optical preclinical imaging is a non-invasive method used for visualizing cellular and molecular processes within living organisms, primarily small animals. It encompasses various techniques like bioluminescence, fluorescence, and other photon-based imaging methods. These systems are crucial in drug development and other biological research fields for their ability to provide real-time insight into biological processes, disease progression, and treatment efficacy. The necessity of optical preclinical imaging lies in its potential to minimize time and costs associated with drug discovery by allowing researchers to make early observations that guide development. Applications extend across oncology, neurology, cardiology, and infectious diseases. The end-use scope notably covers pharmaceutical research, academic settings, and biotechnology firms.

Key growth factors influencing the market include technological advancements, increasing investments in research and development, and rising demand for personalized medicine. The steady push for innovation has paved the path for novel instruments equipped with high-resolution imaging capabilities which are increasingly sought after. However, high costs of equipment and operational complexity pose significant limitations. Regulatory barriers and ethical concerns regarding animal testing also challenge market expansion.

Market opportunities are particularly promising in the development of portable and cost-effective imaging devices and the integration of AI-driven image analysis solutions. Companies can capitalize on these opportunities by investing in R&D partnerships and exploring untapped regional markets. Increased focus on multi-modal imaging techniques, which combine optical imaging with other imaging modalities like MRI or CT, offer another avenue for innovation.

The market is dynamic, driven by rapid technological changes and evolving research needs. Companies need to maintain agility in their strategies, aligning product development with emerging trends such as machine learning applications in image processing. Partnerships with academic institutions might provide collaborative platforms for breakthrough innovations. To thrive, businesses must navigate through technological and ethical landscapes carefully, transforming limitations into innovative solutions to capitalize on the burgeoning demand for sophisticated preclinical imaging solutions.

Understanding Market Dynamics in the Optical Preclinical Imaging Market

The Optical Preclinical Imaging Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increased use of preclinical imaging in different sectors
    • Growing number of clinical research organizations (CROs) and pharmaceutical companies
    • Increasing applications in life science and cosmetic
  • Market Restraints
    • High installation and operational costs
  • Market Opportunities
    • Technological advancement in molecular imaging
    • Rising funding from public-private partnership to support pre clinical researches
  • Market Challenges
    • Strict regulatory framework

Exploring Porter’s Five Forces for the Optical Preclinical Imaging Market

Porter’s Five Forces framework further strengthens the insights of the Optical Preclinical Imaging Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Optical Preclinical Imaging Market

External macro-environmental factors deeply influence the performance of the Optical Preclinical Imaging Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Optical Preclinical Imaging Market

The Optical Preclinical Imaging Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Optical Preclinical Imaging Market

The Optical Preclinical Imaging Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Optical Preclinical Imaging Market

The Optical Preclinical Imaging Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Optical Preclinical Imaging Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies Inc., Analytik Jena GmbH, Angstrom Advanced Inc, Aspect Imaging Ltd., Berthold Technologies GmbH & Co.KG, Bruker Corporation, FUJIFILM Holdings Corporation, General Electric Company, INDEC Systems, Inc., LI-COR, Inc., Magnetic Insight, Inc., MBF Bioscience, Mediso Ltd., Milabs B.V., and Miltenyi Biotec B.V. & Co. KG.

Market Segmentation & Coverage

This research report categorizes the Optical Preclinical Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product Type
    • Consumables
    • Device
      • Bioluminescence
        • Coelenterazine
        • Luciferins
        • Proluciferins
      • Fluorescence
        • Green Fluorescent Proteins
        • Infrared Dyes
        • Red Fluorescent Proteins
    • Software
  • End-Use
    • Pharma & Biotech Companies
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased use of preclinical imaging in different sectors
5.1.1.2. Growing number of clinical research organizations (CROs) and pharmaceutical companies
5.1.1.3. Increasing applications in life science and cosmetic
5.1.2. Restraints
5.1.2.1. High installation and operational costs
5.1.3. Opportunities
5.1.3.1. Technological advancement in molecular imaging
5.1.3.2. Rising funding from public-private partnership to support pre clinical researches
5.1.4. Challenges
5.1.4.1. Strict regulatory framework
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Optical Preclinical Imaging Market, by Product Type
6.1. Introduction
6.2. Consumables
6.3. Device
6.3.1. Bioluminescence
6.3.1.1. Coelenterazine
6.3.1.2. Luciferins
6.3.1.3. Proluciferins
6.3.2. Fluorescence
6.3.2.1. Green Fluorescent Proteins
6.3.2.2. Infrared Dyes
6.3.2.3. Red Fluorescent Proteins
6.4. Software
7. Optical Preclinical Imaging Market, by End-Use
7.1. Introduction
7.2. Pharma & Biotech Companies
7.3. Research Institutes
8. Americas Optical Preclinical Imaging Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Optical Preclinical Imaging Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Optical Preclinical Imaging Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. OPTICAL PRECLINICAL IMAGING MARKET RESEARCH PROCESS
FIGURE 2. OPTICAL PRECLINICAL IMAGING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. OPTICAL PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. OPTICAL PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. OPTICAL PRECLINICAL IMAGING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. OPTICAL PRECLINICAL IMAGING MARKET DYNAMICS
TABLE 7. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COELENTERAZINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY LUCIFERINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PROLUCIFERINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY GREEN FLUORESCENT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY INFRARED DYES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY RED FLUORESCENT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 41. CANADA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. CANADA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 43. CANADA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 44. CANADA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 45. CANADA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. MEXICO OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 49. MEXICO OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 68. CHINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. CHINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 70. CHINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 71. CHINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 72. CHINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 73. INDIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. INDIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 75. INDIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 76. INDIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 77. INDIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 83. JAPAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. JAPAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 85. JAPAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 86. JAPAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 87. JAPAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 113. THAILAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. THAILAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 115. THAILAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 116. THAILAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 117. THAILAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 129. DENMARK OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. DENMARK OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 131. DENMARK OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 132. DENMARK OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 133. DENMARK OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 134. EGYPT OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. EGYPT OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 136. EGYPT OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 137. EGYPT OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 138. EGYPT OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 139. FINLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. FINLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 141. FINLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 142. FINLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 143. FINLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 144. FRANCE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. FRANCE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 146. FRANCE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 147. FRANCE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 148. FRANCE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 149. GERMANY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. GERMANY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 151. GERMANY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 152. GERMANY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 153. GERMANY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 159. ITALY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. ITALY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 161. ITALY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 162. ITALY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 163. ITALY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 174. NORWAY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. NORWAY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 176. NORWAY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 177. NORWAY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 178. NORWAY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 179. POLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. POLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 181. POLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 182. POLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 183. POLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 184. QATAR OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. QATAR OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 186. QATAR OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 187. QATAR OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 188. QATAR OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 204. SPAIN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. SPAIN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 206. SPAIN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 207. SPAIN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 208. SPAIN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 219. TURKEY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. TURKEY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 221. TURKEY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 222. TURKEY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 234. OPTICAL PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 235. OPTICAL PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Optical Preclinical Imaging Market, which are profiled in this report, include:
  • Agilent Technologies Inc.
  • Analytik Jena GmbH
  • Angstrom Advanced Inc
  • Aspect Imaging Ltd.
  • Berthold Technologies GmbH & Co.KG
  • Bruker Corporation
  • FUJIFILM Holdings Corporation
  • General Electric Company
  • INDEC Systems, Inc.
  • LI-COR, Inc.
  • Magnetic Insight, Inc.
  • MBF Bioscience
  • Mediso Ltd.
  • Milabs B.V.
  • Miltenyi Biotec B.V. & Co. KG

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages197
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.51 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.39 Billion
Compound Annual Growth Rate14.3%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Optical Preclinical Imaging Market Size, Share & Trends Analysis Report By Product (Device, Consumables), By End-use (Pharma and Biotech Companies, Research Institutes), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Optical Preclinical Imaging Market Size, Share & Trends Analysis Report By Product (Device, Consumables), By End-use (Pharma and Biotech Companies, Research Institutes), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Optical Preclinical Imaging - Global Strategic Business Report - Product Image

Optical Preclinical Imaging - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Preclinical Imaging Market Size, Share & Trends by Product Type (Optical Imaging, PET, SPECT, Optical Imaging Reagents, Contrast Agents, Nuclear Imaging Reagents), Application (Oncology, Neurology), End User (Pharmaceutical, Imaging Centers) - Forecast to 2029 - Product Image

Preclinical Imaging Market Size, Share & Trends by Product Type (Optical Imaging, PET, SPECT, Optical Imaging Reagents, Contrast Agents, Nuclear Imaging Reagents), Application (Oncology, Neurology), End User (Pharmaceutical, Imaging Centers) - Forecast to 2029

  • Report
  • 591 Pages
  • Global
From
Preclinical Imaging Market Size, Share & Trends Analysis Report By Product (CT Imaging, Reagents, Services), By Application (R&D, Drug Discovery), By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Preclinical Imaging Market Size, Share & Trends Analysis Report By Product (CT Imaging, Reagents, Services), By Application (R&D, Drug Discovery), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Preclinical Imaging Market by Product, Application, End-User - Global Forecast 2025-2030 - Product Image

Preclinical Imaging Market by Product, Application, End-User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.